| NCT-506 |
NCT-506 |
2231098-99-8 |
| Methanone, [4-(1,1-dimethylethyl)-1-piperidinyl][4-(hydroxydiphenylmethyl)-2H-1,2,3-triazol-2-yl]- |
化合物ML-211 |
2205032-89-7 |
| 3(2H)-Pyridazinone, 4-hydroxy-6-[2-[4-(trifluoromethyl)phenyl]ethyl]- |
LUVADAXISTAT |
1425511-32-5 |
| VK-II-86 |
VK II 86|||VKII86 |
955371-84-3 |
| EC144 |
化合物 T22758 |
911397-80-3 |
| 1-(9-ethyl-9H-carbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine |
1-(9-ethyl-9H-carbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine |
880813-42-3 |
| Takeda103A |
Takeda103A |
865609-72-9 |
| 6-Allyldihydronorisolysergic Acid Methyl Ester |
6-Allyldihydronorisolysergic Acid Methyl Ester |
86891-16-9 |
| 4-[4-(2,5-dioxo-1-phenylpyrrolidin-3-yl)piperazin-4-ium-1-yl]phenolate |
ME1 |
522649-59-8 |
| (8β)-N-[3-(Methylamino)propyl]-6-(2-propenyl)-ergoline-8-carboxamide |
(8β)-N-[3-(Methylamino)propyl]-6-(2-propenyl)-ergoline-8-carboxamide |
478815-26-8 |
| Cdk4/6 Inhibitor IV |
G1T28 |
359886-84-3 |
| 1-(4,6-dimethylpyrimidin-2-yl)-3-[2-(trifluoromethyl)phenyl]guanidine |
1-(4,6-dimethylpyrimidin-2-yl)-3-[2-(trifluoromethyl)phenyl]guanidine |
303094-67-9 |
| 302901-13-9 |
RH01687 |
302901-13-9 |
| FAPI-4 |
FAPI-4 |
2374782-02-0 |
| INDEX NAME NOT YET ASSIGNED |
INDEX NAME NOT YET ASSIGNED |
2369751-30-2 |
| OSMI-4 |
OSMI-4 |
2260791-14-6 |
| CCT-367766 |
CCT-367766 |
2229856-58-8 |
| 2-Pyridinecarboxamide, 4-[4-[[[[2-fluoro-5-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]amino]carbonyl]amino]phenoxy]-N-methyl- |
化合物APS6-45 |
2188236-41-9 |
| 3-Pyridinesulfonamide, N-[2-[2-fluoro-4-[[4-(1-methylethyl)-1-piperazinyl]methyl]phenyl]-4-pyridinyl]-2-methoxy-5-(4-morpholinyl)- |
GSK251 |
2125968-05-8 |
| BMS-1166 HCl |
BMS-1166 HCl |
2113650-05-6 |
QQ
微信
